Ruxolitinib versus standard therapy for the treatment of polycythemia vera

Hans C Hasselbalch, Mads E Bjørn

17 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The New England journal of medicine
Vol/bind	372
Udgave nummer	17
Sider (fra-til)	1670
ISSN	0028-4793
DOI	https://doi.org/10.1056/NEJMc1502524#SA1
Status	Udgivet - 23 apr. 2015

Adgang til dokumentet

@article{2eda7786f230481fb1327d1cd761db0b,

title = "Ruxolitinib versus standard therapy for the treatment of polycythemia vera",

keywords = "Antineoplastic Agents, Female, Humans, Janus Kinases, Male, Polycythemia Vera, Pyrazoles",

author = "Hasselbalch, {Hans C} and Bj{\o}rn, {Mads E}",

year = "2015",

month = apr,

day = "23",

doi = "10.1056/NEJMc1502524#SA1",

language = "English",

volume = "372",

pages = "1670",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "17",

}

TY - JOUR

T1 - Ruxolitinib versus standard therapy for the treatment of polycythemia vera

AU - Hasselbalch, Hans C

AU - Bjørn, Mads E

PY - 2015/4/23

Y1 - 2015/4/23

KW - Antineoplastic Agents

KW - Female

KW - Humans

KW - Janus Kinases

KW - Male

KW - Polycythemia Vera

KW - Pyrazoles

U2 - 10.1056/NEJMc1502524#SA1

DO - 10.1056/NEJMc1502524#SA1

M3 - Journal article

C2 - 25901433

SN - 0028-4793

VL - 372

SP - 1670

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 17

ER -